Join Program Chair Nancy M. Holekamp, MD, and fellow retina specialists Sunir J. Garg, MD, FACS, FASRS, and Jennifer I. Lim, MD, for this live-virtual symposium. The panel of experts will discuss the available armamentarium and how those treatments have impacted their patients with diabetic eye disease. The faculty will also review data on newly approved and pipeline therapies and examine which patients could most benefit from these cutting-edge treatments.
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Accreditation & Designation Statements
Provided by Evolve Medical Education 
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, earns credit toward the Lifelong Learning requirement[s] for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting credit.
